C. Andrew Kistler, MD, PharmD, RPh

Andy Kistler MD, PharmD is a Gastroenterology and Hepatology Fellow at Thomas Jefferson University Hospital in Philadelphia, PA. He then earned his MD at Rutgers University-New Jersey Medical School in Newark, NJ. His research interests include the utilization of endoscopic procedures for GI malignancies, anticoagulation and C diff colitis.

Most Recent Articles by C. Andrew Kistler, MD, PharmD, RPh

Volatile Organic Compounds and Esophageal Cancer: Understanding the Implications for Diagnosis and Treatment

Volatile Organic Compounds and Esophageal Cancer: Understanding the Implications for Diagnosis and Treatment

By

While utilization of VOCs in the early detection of esophageal cancer has shown promise, future studies should aim at determining which VOCs would be the most specific in diagnosing GI malignancies.

Sirolimus Use in Graft Versus Host Disease

Sirolimus Use in Graft Versus Host Disease

By

As more experience with sirolimus has been gained, it began to be used "off-label" to prevent rejection in multiple transplant recipients and is now being studied in the treatment of GVHD.

Telotristat for Diarrhea in Patients With Carcinoid Syndrome

Telotristat for Diarrhea in Patients With Carcinoid Syndrome

By

Telotristat represents a new treatment option that may decrease diarrhea incidence with a relatively safe side effect profile.

Immune-mediated Hepatitis: Challenges in Management

Immune-mediated Hepatitis: Challenges in Management

By

The incidence of immune-mediated hepatitis in patients receiving immunotherapy varies based on the agent and other concomitant medications, though it is not uncommon.

Dermatomyositis and Cancer Risk

Dermatomyositis and Cancer Risk

By

Treating physicians should watch for any suspicious signs of cancer after DM is diagnosed.

More Articles by C. Andrew Kistler, MD, PharmD, RPh

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters